Physiotherapy Efficiency on Child Asthma

• Sponsor: University Hospital, Montpellier (Other)
• Overall Status: Completed
• CT.gov ID: NCT02114398
• Collaborator: (none)
• Enrollment: 74
• Location: 1
• Arms: 2
• Duration (Months): 30
• Patients Per Site Per Month: 2.5

Study Details

Study Description

Brief Summary

The study aim is to compare usual asthma crisis treatment of hospitalized children with usual treatment associated to sophrology.

Condition or Disease	Intervention/Treatment	Phase
Child; Asthma Crisis	Other: usual treatment; Other: usual treatment + sophrology	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 74 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: Physiotherapy Efficiency With Caycedian Sophrology on Child Asthma: Randomized, Controlled Study
• Study Start Date: Oct 1, 2013
• Actual Primary Completion Date: Apr 1, 2016
• Actual Study Completion Date: Apr 1, 2016

Arms and Interventions

Arm	Intervention/Treatment
Experimental: usual treatment usual treatment	Other: usual treatment; usual treatment
Experimental: usual treatment + sophrology usual treatment + sophrology	Other: usual treatment + sophrology; usual treatment + sophrology

Outcome Measures

Primary Outcome Measures

1. Peak Expiratory Flow (PEF) [1 day]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 6 Years to 17 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• child (6 to 17 years old)

• hospitalized in pediatric unit for asthma crisis

Exclusion Criteria:

• patient who can't participate because of his healthcare (resuscitation...)

• impossibility to measure Peak Expiratory Flow (PEF)

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Pediatric and Congenital Cardiology and Pulmonology Department, Arnaud De Villeneuve University Hospital	Montpellier		France	34295

Sponsors and Collaborators

• University Hospital, Montpellier

Investigators

• Principal Investigator: Pascal AMEDRO, MD, PhD, UH Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: University Hospital, Montpellier
• ClinicalTrials.gov Identifier: NCT02114398
• Other Study ID Numbers: 9162
• First Posted: Apr 15, 2014
• Last Update Posted: Sep 20, 2018
• Last Verified: Sep 1, 2018

• Additional relevant MeSH terms: Asthma

Study Results

No Results Posted as of Sep 20, 2018